ClinicalTrials.gg
Status unknownNCT04248946RAINDROPUpdated May 3, 2021

Neural, Behavioural, and Clinical Effects of tDCS in PDOC; Feasibility Study

An interventional study of Transcranial direct current stimulation in Consciousness Disorder, Brain Injuries and Vegetative State, sponsored by University of Birmingham. Status unknown at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-03.

Sponsored by University of Birmingham · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the feasibility of an experimental protocol that combines advanced multi-modal imaging of the brain with clinical and behavioural scales to characterise the neural, behavioural, and clinical effects of transcranial direct current stimulation (tDCS) for rehabilitation in PDOC

Read the detailed description

Patients with prolonged disorders of consciousness (PDOC) have very limited therapeutic options, and they often show little to no progress over time. Here, the investigators will assess whether transcranial direct current stimulation can improve patients' responsiveness. The investigators will use a protocol designed to target specific brain networks that have been shown to play a key role in explaining the lack of voluntary responses in PDOC. The study will focus on characterising the mechanisms of action of tDCS and the bases for potential individual differences in responsiveness to the stimulation across participants. This feasibility study is the first step towards developing personalised tDCS interventions to restore external responsiveness in PDOC patients. Its results will inform the design of a future trial fully powered for characterising neural, behavioural, and clinical effects of tDCS in PDOC as well as the mechanisms underlying individual differences in responsiveness.

02

Conditions studied

  • Consciousness Disorder
  • Brain Injuries
  • Vegetative State
  • Minimally Conscious State
03

In context

Consciousness Disorders

290 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

This study's planned enrollment of 15 is below the median of 47 across 191 interventional studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

University of Birmingham is the lead sponsor of 182 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Receiving care at a recruitment site, with a consensus clinical diagnosis of PDOC from any aetiology (i.e. traumatic or non-traumatic injury).
  • Stable and with no need of mechanical support (i.e. respirator, etc.)

Exclusion criteria

Exclusion Criteria:

  • Scalp skin sores or any skin damage at the electrode sites
  • Metallic implants in the face or skull
  • Craniectomy or cranioplasty
  • No evidence of auditory startle in clinical observations, or absent brainstem auditory evoked potentials in recent clinical history (if data available)
  • MRI incompatible: metal plates incompatible with MRI scanners, pacemaker, inability to lay flat for prolonged periods of time, aneurysm clips, neurostimulators, brain/subdural electrodes, etc. (MRI stream ONLY)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    MRI stream

    In this stream all patients receive 2 experimental interventions (anodal tDCS and cathodal tDCS) and a sham intervention (sham tDCS). These are delivered in randomised order, ensuring a balanced distribution of participants across possible orders. They will receive 5 sessions per condition (on consecutive days), for a total of 15 sessions. I. Anodal, cathodal, sham II. Anodal, sham, cathodal III. Cathodal, anodal, sham IV. Cathodal, sham, anodal V. Sham, anodal, cathodal VI. Sham, cathodal, anodal

    Other: Transcranial direct current stimulation

  • Experimental
    Bedside stream

    In this stream all patients receive 1 experimental interventions (either anodal tDCS or cathodal tDCS) and 1 sham intervention (sham tDCS). These include only 1 session per condition and are delivered in randomised order, resulting in the following possible combinations: I. Anodal, sham II. Cathodal, sham III. Sham, anodal IV. Sham, cathodal Participants will be randomly assigned to the above groups ensuring a balanced distribution of participants across them.

    Other: Transcranial direct current stimulation

Interventions

  • OtherTranscranial direct current stimulation

    tDCS alters neural excitability in a polarity-specific manner via a weak direct electric current delivered through electrodes placed on the scalp. There are 3 types of stimulation: anodal, cathodal, and sham. In anodal tDCS, the positive electrode is placed over the target brain area to increase neuronal excitability. In cathodal tDCS, the negative electrode is placed over the target brain area to decrease neuronal excitability. Sham tDCS emulates the physical sensations of active (anodal/cathodal) tDCS but current is only delivered for a short period of time and is not enough to cause any neuromodulations

    Also known as: tDCS

06

What researchers measure

Primary outcomes

  1. Retention at end of active phase

    percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure)

    Time frame: through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream

  2. Retention at 3 months

    percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only

    Time frame: 3 months after start of participation

  3. Retention at 6 months

    percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only

    Time frame: 6 months after start of participation

  4. Completion

    percentage of tDCS, MRI, and electrophysiology assessments completed per polarity

    Time frame: through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream

Secondary outcomes

  1. Structural MRI

    This will include assessments of the gross macrostructure, and microstructure of brain tissue grey matter, white matter, and cerebrospinal fluid

    Time frame: day 1 and day 5 of tDCS each polarity

  2. Functional MRI in response to task instructions

    This will include assessments of the BOLD (blood oxygen level-dependent) response to characterise brain activity and connectivity during command following

    Time frame: day 1 and day 5 of tDCS each polarity

  3. EEG power in the alpha band in response to task instructions

    Envelope of bandpass filtered EEG data between 8-12 Hertz

    Time frame: days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream

  4. EEG power in the beta band in response to task instructions

    Envelope of bandpass filtered EEG data between 13-30 Hertz

    Time frame: days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream

  5. EMG (electromyography) amplitude changes

    Changes in the amplitude of the rectified EMG signal (high-pass filtered \> 50Hz) in response to instructions to move

    Time frame: days 1-4 and day 2 of each polarity in the MRI and bedside streams respectively

  6. Coma recovery scale -revised

    clinical diagnostic scale for disorders of consciousness. Total score ranges from 0 to 23, where higher scores mean a higher level of functioning and awareness

    Time frame: regularly through active phase of study (baseline and outcome assessments), on average 4 weeks for bedside stream and 8 weeks for MRI stream

  7. Glasgow Outcome Scale-extended

    Scale for functional outcome after brain injury. Total score ranges from 1 to 8, where higher values correspond to better outcome

    Time frame: at 3 and 6 months after start of participation

07

Study locations

2 sites
  • Moseley Hall Hospital
    Birmingham, West Midlands B13 8JL, United Kingdom
  • The Wellington Hospital
    London, NW8 9LE, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04248946
Collaborators
Wellington Hospital
Responsible party
Sponsor
First posted
Jan 30, 2020
Start date
Jul 2021 (estimated)
Primary completion
Aug 2022 (estimated)
Completion
Aug 2022 (estimated)
Last update
May 3, 2021

Study contacts

Davinia Fernandez Espejo, PhD FHEA
Contact
d.fernandez-espejo@bham.ac.uk
01214145534

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion